Article
Dr. Bimal Patel Discusses the Rising Costs of Generic Drugs
Bimal Patel, PharmD, MS, Director, Health Outcomes Research, MedImpact Healthcare Systems, Inc., discusses MedImpact's work to identify, analyze, and evaluate generic medications that have become significantly expensive, and effective strategies for managing these costs.
Bimal Patel, PharmD, MS, Director, Health Outcomes Research, MedImpact Healthcare Systems, Inc., discusses MedImpact’s work to identify, analyze, and evaluate generic medications that have become significantly expensive, and effective strategies for managing these costs.
Dr. Patel also discusses the importance of communication among pharmacy benefit managers, plan sponsors, and physicians as generic drug costs continue to rise.
Related Content
